Open access · CC-BY
via OpenAlex
Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice
Maria Elisa Giuliani, Veronica Barbi, Giorgia Bigossi, Serena Marcozzi, Robertina Giacconi, Maurizio Cardelli, Francesco Piacenza, Fiorenza Orlando, Elena Ciaglia, Monica Cattaneo, Alessia Mongelli, Carlo Gaetano, Mauro Provinciali, Annibale Alessandro Puca, Marco Malavolta
International Journal of Molecular Sciences · 2023 · ▲ 7 citations
Abstract
The homozygous genotype of the Longevity-Associated Variant (LAV) in Bactericidal/Permeability-Increasing Fold-Containing Family B member 4 (BPIFB4) is enriched in long-living individuals of three independent populations and its genetic transfer in C57BL/6J mice showed a delay in frailty progression and improvement of several biomarkers of aging and multiple aspects of health. The C57BL/6J strain is a suitable model for studying therapies aimed at extending healthy aging and longevity due to its relatively short lifespan and the availability of aging biomarkers. Epigenetic clocks based on DNA methylation profiles are reliable molecular biomarkers of aging, while frailty measurement tools are used to evaluate overall health during aging. In this study, we show that the systemic gene transfer of LAV-BPIFB4 in aged C57BL/6J mice was associated with a significant reduction in the epigenetic clock(definition)-based biological age, as measured by a three CpG clock method. Furthermore, LAV-BPIFB4 gene transfer resulted in an improvement of the Vitality Score with a reduction in the Frailty Index. These findings further support the use of LAV-BPIFB4 gene therapy to induce beneficial effects on epigenetic mechanisms associated with aging and frailty in aged mice, with potential implications for future therapies to prevent frailty in humans.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms24076464
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Giuliani, M.E., Barbi, V., Bigossi, G., Marcozzi, S., Giacconi, R., Cardelli, M., Piacenza, F., Orlando, F., Ciaglia, E., Cattaneo, M., Mongelli, A., Gaetano, C., Provinciali, M., Puca, A.A., & Malavolta, M. (2023). Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms24076464
Vancouver
Giuliani ME, Barbi V, Bigossi G, Marcozzi S, Giacconi R, Cardelli M, et al. Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076464.
BibTeX
@article{maria2023Effect,
title = {Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice},
author = {Maria Elisa Giuliani and Veronica Barbi and Giorgia Bigossi and Serena Marcozzi and Robertina Giacconi and Maurizio Cardelli and Francesco Piacenza and Fiorenza Orlando and Elena Ciaglia and Monica Cattaneo and Alessia Mongelli and Carlo Gaetano and Mauro Provinciali and Annibale Alessandro Puca and Marco Malavolta},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076464},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Aging 2026
Open access · CC-BY
Longitudinal changes in epigenetic clocks predict survival in the InCHIANTI cohort
Genetics and Molecular Research 2025
Open access · CC-BY
Evolution Epigenetic Age and DNA Methylation Biomarkers for Monitoring Physiological Stress and Healthy Aging
Journal of Proteome Research 2014
Open access · OA
Metabolomics Analysis Uncovers That Dietary Restriction Buffers Metabolic Changes Associated with Aging in Caenorhabditis elegans
Aging Cell 2008
Citation only
Variation in mitochondrial genotype has substantial lifespan effects which may be modulated by nuclear background
Breast Cancer Research 2017
Open access · CC-BY
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer
The Journals of Gerontology Series A 2026
Open access · CC-BY